Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Kalaris Therapeutics Inc. (KLRS) had Weighted-Average Shares Outstanding (Diluted) of 18.70M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.89M |
|
-- |
|
-- |
|
$12.74M |
|
$-12.74M |
|
$0.85M |
|
$-11.89M |
|
$-11.89M |
|
$-11.89M |
|
$-11.89M |
|
$-11.89M |
|
$-11.89M |
|
$-12.74M |
|
$-12.74M |
|
18.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
18.70M |
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$78.18M |
|
-- |
|
$2.99M |
|
$81.17M |
|
$6.07M |
|
-- |
|
$33.24M |
|
$39.31M |
|
$41.87M |
|
$41.87M |
|
$41.87M |
|
18.70M |
|
| Cash Flow Statement Financials | |
$-31.31M |
|
$-34.71M |
|
$107.27M |
|
$1.64M |
|
$42.89M |
|
$41.25M |
|
$1.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.41% |
|
-28.41% |
|
-14.65% |
|
-28.41% |
|
$2.24 |
|
$-1.68 |
|
$-1.67 |
|